ChitiA., AgrestiR., MaffioliL.S., TomasicG., SavelliG., CrippaF., PilottiS., GrecoM., BombardieriE.: Breast cancer staging using [99mTc]-sestamibi and [111In]-pentetreotide single photon emission tomography.Eur. J. Nuc. Med., 24: 192–196, 1997.
2.
ChitiA., MaffioliL.S., InfanteM., GrasselliG., IncarboneM., GaspariniM.D., SavelliG., BombardieriE.: Assessment of mediastinal involvement in lung cancer with 99mTc-Ses-taMIBI SPET.J. Nucl. Med., 37: 938–942, 1996.
3.
ChiuM.L., KronaugeJ.F., Piwnica-WormsD.: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)-technetium(I) in cultured mouse fibroblasts.J. Nucl. Med., 31: 1646–1653, 1990.
4.
EllP.J.: Keeping abreast of time.Eur. J. Nucl. Med., 22: 967–969, 1995.
5.
GianniA.M., SienaS., BregniM., Di NicolaM., OreficeS., SalvadoriB., LuiniA., GrecoM., ZucaliR., RilkeF., Zam-bettiM., ValagussaP., BonadonnaG.: Efficacy, toxicity and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more axillary nodes involved - five years results.J. Clin. Oncol., 1997, in press.
6.
HendersonI.C.: Breast cancer.In: Harrison's principles of internal medicine,IsselbacherK.J., BraumwaldE., WilsonJ.D., MartinJ.B., FauciA.S., KasperD.L. (Eds.), 13th ed., pp. 1840–1850, McGraw-Hill Inc., New York, 1994.
7.
KhalkhaliI., MenaI., JouanneE.: Prone scintimammography in patients with suspicions of carcinoma of the breast.J. Am. Coll. Surg., 178: 491–497, 1994.
8.
LamW.W.M., YangW.T., ChanY.L., StewartI.E.T., Me-treweliC., KingW.: Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography.Eur. J. Nuc. Med., 23: 498–503, 1996.
9.
MaffioliL., SteensJ., PauwelsE.J., BombardieriE.: Applications of Tc-99m-sestamibi in oncology.Tumori, 82: 12–21, 1996.
10.
MaffioliL.S., GaspariniM., ChitiA., GramagliaA., MongiojV., PozziA., BombardieriE.: Clinical role of Tc99m-Ses-taMIBI SPET in evaluating pretreated patients with brain tumors.Eur. J. Nucl. Med., 23: 308–311, 1996.